Your browser doesn't support javascript.
loading
Effect of Maternal Immunization With 10-Valent Pneumococcus Conjugate Vaccine (PCV-10), 23-Valent Pneumococcus Polysaccharide Vaccine, or Placebo on the Immunogenicity of PCV-10 in Human Immunodeficiency Virus-Exposed Uninfected Infants: A Randomized Clinical Trial.
Mussi-Pinhata, Marisa M; Ward, Shawn; Laimon, Lauren; Pelton, Stephen I; Canniff, Jennifer; Golner, Amanda; Bone, Frederic; Newton, Lassallete; Muresan, Petronella; Fenton, Terence; Johnson, Michael J; João, Esau C; Santos, Breno R; Pilotto, Jose H; Oliveira, Ricardo H; Pinto, Jorge A; Dal Bó, Andrea G B L; Kreitchmann, Regis; Chakhtoura, Nahida; Duarte, Geraldo; Weinberg, Adriana.
Afiliação
  • Mussi-Pinhata MM; Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Ward S; Frontier Science Foundation, Brookline, Massachusetts, USA.
  • Laimon L; Westat, Rockville, Maryland, USA.
  • Pelton SI; Boston University School of Medicine, Boston, Massachusetts, USA.
  • Canniff J; Colorado University Anschutz Medical Campus, Aurora, Colorado, USA.
  • Golner A; Frontier Science Foundation, Buffalo, New York, USA.
  • Bone F; Frontier Science Foundation, Buffalo, New York, USA.
  • Newton L; Westat, Rockville, Maryland, USA.
  • Muresan P; Frontier Science Foundation, Brookline, Massachusetts, USA.
  • Fenton T; Frontier Science Foundation, Brookline, Massachusetts, USA.
  • Johnson MJ; Colorado University Anschutz Medical Campus, Aurora, Colorado, USA.
  • João EC; Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil.
  • Santos BR; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
  • Pilotto JH; Hospital Geral de Nova Iguaçu and Laboratório de AIDS e Imunologia Molecular-Fiocruz, Rio de Janeiro, Brazil.
  • Oliveira RH; Instituto de Puericultura e Pediatria Martagão Gesteira, Rio de Janeiro, Brazil.
  • Pinto JA; School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Dal Bó AGBL; Health Research Institute, University of Caxias do Sul, Caxias do Sul, Brazil.
  • Kreitchmann R; Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
  • Chakhtoura N; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
  • Duarte G; Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Weinberg A; Colorado University Anschutz Medical Campus, Aurora, Colorado, USA.
Clin Infect Dis ; 75(6): 996-1005, 2022 09 29.
Article em En | MEDLINE | ID: mdl-35037049
ABSTRACT

BACKGROUND:

The effect of pneumococcal vaccination of mothers with human immunodeficiency virus (HIV) on infant responses to childhood vaccination has not been studied. We compared the immunogenicity of 10-valent pneumococcus conjugate vaccine (PCV-10) in HIV-exposed uninfected infants born to mothers who received PCV-10, 23-valent pneumococcus polysaccharide vaccine (PPV-23), or placebo during pregnancy.

METHODS:

Antibody levels against 7 serotypes were measured at birth, before the first and second doses of PCV-10m and after completion of the 2-dose regimen in 347 infants, including 112 born to mothers who received PPV-23, 112 who received PCV-10, and 119 who received placebo during pregnancy. Seroprotection was defined by antibody levels ≥0.35 µg/mL.

RESULTS:

At birth and at 8 weeks of life, antibody levels were similar in infants born to PCV-10 or PPV-23 recipients and higher than in those born to placebo recipient. After the last dose of PCV-10, infants in the maternal PCV-10 group had significantly lower antibody levels against 5 serotypes than those in the maternal PPV-23 group and against 3 serotypes than those in the maternal placebo group, and they did not have higher antibody levels against any serotype. The seroprotection rate against 7 serotypes was 50% in infants in the maternal PCV-10 group, compared with 71% in both of the maternal PPV-23 and placebo groups (P < .001).

CONCLUSIONS:

Administration of PCV-10 during pregnancy was associated with decreased antibody responses to PCV-10 and seroprotection rates in infants. Considering that PCV-10 and PPV-23 had similar immunogenicity in pregnant women with HIV and that administration of PPV-23 did not affect the immunogenicity of PCV-10 in infants, PPV-23 in pregnancy may be preferred over PCV-10.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Infecções por HIV Tipo de estudo: Clinical_trials Limite: Female / Humans / Infant / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Infecções por HIV Tipo de estudo: Clinical_trials Limite: Female / Humans / Infant / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article